Alaska Women's Cancer Care
Anchorage, Alaska, United States
Oncologist in Anchorage, Alaska
3851 Piper St u264, Anchorage, AK 99508
About Alaska Women's Cancer Care
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
90
Alliance for Clinical Trials in Oncology
35
SWOG Cancer Research Network
31
ECOG-ACRIN Cancer Research Group
17
Gynecologic Oncology Group
5
GOG Foundation
4
NRG Oncology
3
Children's Oncology Group
2
Wake Forest University Health Sciences
2
Eastern Cooperative Oncology Group
1
ImmunoGen, Inc.
1
Clinical Trials at Alaska Women's Cancer Care
During the past decade, Alaska Women's Cancer Care conducted 126 clinical trials. In the 10-year time frame, 126 clinical trials started and 64 clinical trials were completed, i.e. on
average, 50.8% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 46 clinical trials were completed. i.e. 127.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
2007-10-12
2024-12-01
Active, not recruiting
701
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2012-06-18
Unknown status
1,070
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
2009-01-29
2023-09-21
Active, not recruiting
247
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
2009-09-01
Recruiting
360
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
2009-06-29
2024-07-28
Active, not recruiting
813
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Alaska Women's Cancer Care" #1 sponsor was "National Cancer Institute (NCI)" with 90 trials, followed by "Alliance for Clinical Trials in Oncology" with 35 trials
sponsored, "SWOG Cancer Research Network" with 31 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored and "Gynecologic Oncology Group"
with 17 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Alaska Women's Cancer Care"
#1 collaborator was "National Cancer Institute (NCI)" with 98 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were
collaborators in the rest 30 trials.
Clinical Trials Conditions at Alaska Women's Cancer Care
According to Clinical.Site data, the most researched conditions in "Alaska Women's Cancer Care" are
"Recurrent Ovarian Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Invasive Breast Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials) and "Ovarian Seromucinous Carcinoma" (6 trials). Many other conditions were trialed in "Alaska Women's Cancer Care" in a lesser frequency.
Clinical Trials Intervention Types at Alaska Women's Cancer Care
Most popular intervention types in "Alaska Women's Cancer Care" are "Drug" (158 trials), "Other" (114 trials), "Biological" (83 trials), "Procedure" (54 trials) and "Radiation" (26 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (56 trials), "Quality-of-Life Assessment" (48 trials), "Computed Tomography" (32 trials), "Questionnaire Administration" (30 trials) and "Biospecimen Collection" (28 trials). Other intervention names were less common.
Clinical Trials Genders at Alaska Women's Cancer Care
The vast majority of trials in "Alaska Women's Cancer Care" are
155 trials for "All" genders, 35 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Alaska Women's Cancer Care
Currently, there are NaN active trials in "Alaska Women's Cancer Care".
undefined are not yet recruiting,
60 are recruiting,
94 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 25 completed trials in Alaska Women's Cancer Care,
5 suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Alaska Women's Cancer Care, 6 "Phase 1"
clinical trials were conducted, 102 "Phase 2" clinical
trials and 94 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".